EG7 - Pivoting to higher growth
2023-09-28 08:30:00
Redeye updates on EG7 following the new strategy that was announced in connection with the company’s CMD which will pivot EG7 towards higher growth and profitability. We find the new strategy attractive and we have raised our long-term forecasts supporting an increased valuation range with a new base case of SEK55 (SEK50).
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/